On January 25, 2018 National and regional newspapers in The Netherlands published an article on the MESOPEC study. Investigator dr. Eva Madsen and a patient are interviewed. MESOPEC is a phase II study with MesoPher in peritoneal mesothelioma.
The article (in Dutch) can be found on: https://www.ad.nl/wetenschap/veelbelovende-behandelmethode-tegen-asbestkanker~a900b9dc/